RHOG
Basic information
Region (hg38): 11:3826978-3840959
Previous symbols: [ "ARHG" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RHOG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 4 | 0 | 0 |
Variants in RHOG
This is a list of pathogenic ClinVar variants found in the RHOG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-3827618-C-T | not specified | Uncertain significance (May 24, 2024) | ||
11-3827631-C-T | not specified | Uncertain significance (Sep 22, 2021) | ||
11-3827718-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
11-3827860-C-T | Uncertain significance (Oct 01, 2024) | |||
11-3827993-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
11-3828006-C-T | RHOG-related condition | Likely benign (Apr 29, 2024) | ||
11-3828104-C-T | Inborn genetic diseases | Uncertain significance (Aug 29, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RHOG | protein_coding | protein_coding | ENST00000351018 | 1 | 14006 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.430 | 0.541 | 125742 | 0 | 2 | 125744 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.49 | 49 | 128 | 0.381 | 0.00000906 | 1225 |
Missense in Polyphen | 16 | 57.178 | 0.27983 | 639 | ||
Synonymous | -2.44 | 82 | 58.3 | 1.41 | 0.00000460 | 401 |
Loss of Function | 1.74 | 1 | 5.34 | 0.187 | 2.30e-7 | 59 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for the formation of membrane ruffles during macropinocytosis. Plays a role in cell migration and is required for the formation of cup-like structures during trans-endothelial migration of leukocytes. In case of Salmonella enterica infection, activated by SopB and ARHGEF26/SGEF, which induces cytoskeleton rearrangements and promotes bacterial entry. {ECO:0000269|PubMed:15133129, ECO:0000269|PubMed:17074883, ECO:0000269|PubMed:17875742, ECO:0000269|PubMed:20679435}.;
- Pathway
- Salmonella infection - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Shigellosis - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Signaling by GPCR;Neutrophil degranulation;Signal Transduction;RHO GTPases activate KTN1;Innate Immune System;Immune System;Rho GTPase cycle;GPVI-mediated activation cascade;Platelet activation, signaling and aggregation;RHO GTPase Effectors;Signaling by Rho GTPases;Hemostasis;G alpha (12/13) signalling events;Integrin-linked kinase signaling;GPCR downstream signalling;Neurotrophic factor-mediated Trk receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.218
Intolerance Scores
- loftool
- 0.0878
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.64
Haploinsufficiency Scores
- pHI
- 0.589
- hipred
- Y
- hipred_score
- 0.767
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.736
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rhog
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- actin filament organization;establishment or maintenance of cell polarity;Rho protein signal transduction;positive regulation of cell population proliferation;regulation of cell shape;Rac protein signal transduction;actin cytoskeleton organization;regulation of actin cytoskeleton organization;neutrophil degranulation;positive regulation of transcription, DNA-templated;phosphatidylinositol phosphorylation;regulation of small GTPase mediated signal transduction;positive regulation of protein kinase B signaling;cell chemotaxis;activation of GTPase activity;regulation of ruffle assembly;positive regulation of protein localization to plasma membrane
- Cellular component
- cytoplasm;endoplasmic reticulum membrane;cytosol;plasma membrane;focal adhesion;cell cortex;secretory granule membrane;cell projection;extracellular exosome
- Molecular function
- GTPase activity;protein binding;GTP binding;protein kinase binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity